MCADD 2023 _ Event Postponement
This is to inform that due to some circumstances beyond the organizer control, “International Conference on Medicinal Chemistry, Computer Aided Drug Design and Delivery” (MCADD 2023) Hybrid event during September 14-16, 2023 at Valencia, Spain has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at medicinal-chemistry@magnusconference.com or call + 1 (702) 988 2320.
International Conference on Medicinal Chemistry, Computer Aided Drug Design and Delivery
September 14-16, 2023
Pharmacokinetic Behaviour and Pharmacodynamics
- Molecular Pharmacodynamics Significance
- Potential & Challenges
- Clinical Efficacy & Safety
Clinical pharmacology is the study of how drugs interact with the human body. Clinical pharmacology is divided into two sections: pharmacokinetics and pharmacodynamics. Pharmacokinetics and pharmacodynamics, which both play a key role in assessing a drug's safety and efficacy, measure and describe the complex biochemical interactions that occur between the body's natural processes and the chemical composition of a pharmaceutical drug. The FDA, for example, is in charge of approving new pharmaceuticals and deciding whether or not a drug should be taken off the market. Regulatory bodies are also in charge of ensuring that all pharmaceuticals on the market are both effective and safe for human consumption.The primary difference between pharmacokinetics and pharmacodynamics is that pharmacokinetics (PK) refers to drug movement in the body, whereas pharmacodynamics (PD) refers to the body's biological response to drugs. In other words, PK refers to a drug's absorption, distribution, metabolism, and excretion (often referred to as ADME), whereas PD refers to how biological systems in the body respond to or are influenced by a drug. Pharmacokinetics is what the body does to the medication, and pharmacodynamics is what the drug does to the body, to put it simply.
Submit your abstract Today
Title : A qsar survey on tyrosine kinase inhibitors
Atefeh Hajiagha Bozorgi, Faculty of pharmacy, Iran (Islamic Republic of)
Title : Abbott diagnostics: COVID-19 inactivation, nucleocapsid antigen automated immunoassay development, and variant testing for automated and lateral flow assays binaxnow™ and panbio™
Philip M Hemken, Abbott Laboratories, United States
Title : Synthesis, antibacterial activity of 3-amino 5-methoxyl-2-methyl quinazolin-4(3H)-one an amino-6-methoxyl-2-methyl of 4H–benzo[d] [1,3]–oxazine–4–one
Osarumwense Peter Osarodion, Ondo State University of Sciences and Technology, Nigeria
Title : Tackling mycobacterium tuberculosis resistance with tailored isatin-pyrimidine hybrids enoyl acyl carrier protein reductase (Inha)
Amgad Albohy, The British University in Egypt (BUE), Egypt
Title : Transition metal complexes/Organometallic compounfs as anticancer drugs
Prakash kinthda, Nims university,jaipur,rajasthan, India
Title : New n-ribosides and n-mannosides of rhodanine derivatives with anticancer activity on leukaemia cell line: Design, synthesis, dft and molecular modelling studies
Ahmed, Kafrelsheikh University, Egypt